Tianjin Pharmaceutical Da Ren Tang Appoints New Representative for A-Share Placement Oversight

SGX Filings
03/24

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced on Mar, 24 2026 that China Galaxy Securities Co., Ltd., its placement agent for the A-share placement initiated in Jul, 2015, has replaced one of its supervisory representatives.

Due to a change in work arrangements, Mr. Wang Jianlong will no longer serve in the role. Galaxy Securities has appointed Ms. Wang Han to assume the continuous supervision duties alongside existing representative Ms. Kang Yuan.

Although the formal supervision period for the placement has concluded, some proceeds from the fundraising remain unutilised, and the placement agent will continue to monitor the deposit and use of these funds.

The board expressed gratitude to Mr. Wang Jianlong for his contributions and confirmed that Ms. Wang Han, a sponsor representative with six years of investment-banking experience, will take over immediately.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10